Sally Mossman

1.4k total citations
20 papers, 1.0k citations indexed

About

Sally Mossman is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Sally Mossman has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Immunology and 6 papers in Virology. Recurrent topics in Sally Mossman's work include Herpesvirus Infections and Treatments (7 papers), HIV Research and Treatment (6 papers) and Immunotherapy and Immune Responses (6 papers). Sally Mossman is often cited by papers focused on Herpesvirus Infections and Treatments (7 papers), HIV Research and Treatment (6 papers) and Immunotherapy and Immune Responses (6 papers). Sally Mossman collaborates with scholars based in United States, Belgium and United Kingdom. Sally Mossman's co-authors include David H. Persing, Christopher W. Cluff, Jory R. Baldridge, Jay T. Evans, Patrick O. McGowan, David A. Johnson, Sandra L. Giannini, Najoua Dendouga, Benoı̂t Baras and Martine Wettendorff and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Sally Mossman

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally Mossman United States 15 597 448 263 226 185 20 1.0k
Dominick J. Laddy United States 20 513 0.9× 675 1.5× 613 2.3× 152 0.7× 235 1.3× 25 1.3k
Beatrice M. Senn Switzerland 18 424 0.7× 595 1.3× 242 0.9× 81 0.4× 199 1.1× 23 1.3k
Russell Vassell United States 20 441 0.7× 602 1.3× 545 2.1× 391 1.7× 266 1.4× 41 1.4k
Frédéric Clément Belgium 21 1.1k 1.8× 840 1.9× 649 2.5× 207 0.9× 432 2.3× 39 1.9k
Elanchezhiyan Manickan United States 15 694 1.2× 746 1.7× 229 0.9× 106 0.5× 298 1.6× 28 1.3k
Susette Audet United States 24 1.4k 2.4× 652 1.5× 624 2.4× 110 0.5× 147 0.8× 38 2.0k
Susan J. Best Australia 14 300 0.5× 243 0.5× 199 0.8× 276 1.2× 148 0.8× 21 888
Morag Ferguson United Kingdom 19 352 0.6× 117 0.3× 377 1.4× 173 0.8× 224 1.2× 32 947
Daniel C. Freed United States 25 1.0k 1.7× 914 2.0× 425 1.6× 441 2.0× 361 2.0× 47 2.0k
Catherine Collignon Belgium 14 379 0.6× 788 1.8× 364 1.4× 392 1.7× 418 2.3× 20 1.4k

Countries citing papers authored by Sally Mossman

Since Specialization
Citations

This map shows the geographic impact of Sally Mossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Mossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Mossman more than expected).

Fields of papers citing papers by Sally Mossman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Mossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Mossman. The network helps show where Sally Mossman may publish in the future.

Co-authorship network of co-authors of Sally Mossman

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Mossman. A scholar is included among the top collaborators of Sally Mossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Mossman. Sally Mossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plotkin, Stanley A., Dai Wang, Don J. Diamond, et al.. (2019). The Status of Vaccine Development Against the Human Cytomegalovirus. The Journal of Infectious Diseases. 221(Supplement_1). S113–S122. 79 indexed citations
2.
Marchevsky, Renato Sérgio, Ana María Bispo de Filippis, Pedro Fernando da Costa Vasconcelos, et al.. (2018). Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques. PLoS ONE. 13(4). e0196311–e0196311. 7 indexed citations
3.
Fernandez, Stefan, Stephen J. Thomas, Rafael De La Barrera, et al.. (2015). An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques. American Journal of Tropical Medicine and Hygiene. 92(4). 698–708. 49 indexed citations
4.
Schleiss, Mark R., K. Yeon Choi, Jodi Anderson, et al.. (2013). Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model. Vaccine. 32(23). 2756–2762. 40 indexed citations
5.
Dendouga, Najoua, et al.. (2012). Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice. Vaccine. 30(20). 3126–3135. 116 indexed citations
6.
Baras, Benoı̂t, et al.. (2012). Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs. Vaccine. 30(37). 5557–5563. 9 indexed citations
7.
Baras, Benoı̂t, Leon de Waal, Koert J. Stittelaar, et al.. (2011). Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets. Vaccine. 29(11). 2120–2126. 22 indexed citations
8.
Baras, Benoı̂t, Koert J. Stittelaar, Thijs Kuiken, et al.. (2011). Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets. Vaccine. 29(11). 2092–2099. 16 indexed citations
9.
Mossman, Sally, et al.. (2011). Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity. Expert Review of Vaccines. 10(12). 1709–1715. 53 indexed citations
10.
Baras, Benoı̂t, Koert J. Stittelaar, James H. Simon, et al.. (2008). Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine. PLoS ONE. 3(1). e1401–e1401. 142 indexed citations
11.
Mossman, Sally, Han-hua Fang, Jay K. Staas, et al.. (2005). Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants. Vaccine. 23(27). 3545–3554. 5 indexed citations
12.
Henderson, Rogene, et al.. (2005). Cancer vaccines and immunotherapies: emerging perspectives. Vaccine. 23(17-18). 2359–2362. 30 indexed citations
13.
Mossman, Sally, Andrew J. Watson, Michael Robertson, et al.. (2004). Protective Immunity to SIV Challenge Elicited by Vaccination of Macaques with Multigenic DNA Vaccines Producing Virus-Like Particles. AIDS Research and Human Retroviruses. 20(4). 425–434. 19 indexed citations
14.
Baldridge, Jory R., Patrick O. McGowan, Jay T. Evans, et al.. (2004). Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opinion on Biological Therapy. 4(7). 1129–1138. 213 indexed citations
15.
Bradshaw, Jeffrey D., William F. Sutton, LaRene Kuller, et al.. (2000). Macaque blood‐derived antigen‐presenting cells elicit SIV‐specific immune responses. Journal of Medical Primatology. 29(3-4). 182–192. 14 indexed citations
16.
O'Neil, S P, Sally Mossman, Donald H. Maul, & Edward A. Hoover. (1999). Virus Threshold Determines Disease in SIVsmmPBj14-Infected Macaques. AIDS Research and Human Retroviruses. 15(2). 183–194. 7 indexed citations
17.
O’Neil, Shawn P., Sally Mossman, Donald H. Maul, & Edward A. Hoover. (1999). In Vivo Cell and Tissue Tropism of SIVsmmPBj14-bcl.3. AIDS Research and Human Retroviruses. 15(2). 203–215. 14 indexed citations
18.
Mossman, Sally, Michael Robertson, Andrew J. Watson, et al.. (1999). Immunization against SIVmne in macaques using multigenic DNA vaccines. Journal of Medical Primatology. 28(4-5). 206–213. 16 indexed citations
19.
Mossman, Sally, Françoise Bex, Peter Berglund, et al.. (1996). Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. Journal of Virology. 70(3). 1953–1960. 130 indexed citations
20.
Israel, Zimra R., Donald H. Maul, S P O'Neil, et al.. (1994). Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. Journal of Virology. 68(3). 1843–1853. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominick J. Laddy Breakdown of academic impact, for papers by Beatrice M. Senn Breakdown of academic impact, for papers by Russell Vassell Breakdown of academic impact, for papers by Frédéric Clément Breakdown of academic impact, for papers by Elanchezhiyan Manickan Breakdown of academic impact, for papers by Susette Audet Breakdown of academic impact, for papers by Susan J. Best Breakdown of academic impact, for papers by Morag Ferguson Breakdown of academic impact, for papers by Daniel C. Freed Breakdown of academic impact, for papers by Catherine Collignon
Rankless by CCL
2026